Riichi Maki

Title: **Innovative Contributions of Riichi Maki in Metabolic and Oral Health**

Introduction

Riichi Maki is an accomplished inventor based in Tokyo, Japan. With a focus on health-related technologies, Maki has made significant strides through his patented inventions that aim to improve diagnostics and treat conditions such as metabolic syndrome and oral health issues.

Latest Patents

Riichi Maki holds two noteworthy patents. The first is a **Marker peptide for determining risk of developing metabolic syndrome, and use thereof**. This invention offers a marker substance that accurately assesses the risk of developing metabolic syndrome in vivo. The patent details the creation of a marker peptide, along with an antibody or an aptamer bound to it. Additionally, it includes a microarray featuring the immobilized elements and outlines a method for determining risk through biological samples, accompanied by a diagnostic kit.

The second patent is an **Analytical tool and method for determining a condition of an oral cavity**. This innovative method uses a specialized analytical tool composed of components that facilitate the assessment of oral health conditions.

Career Highlights

Throughout his career, Maki has collaborated with reputable companies like Lion Corporation and Arkray, Inc., applying his expertise in innovative technologies. His contributions to these organizations have played a pivotal role in advancing research and development in health-related fields.

Collaborations

Maki has worked alongside notable coworkers, including Chiyoko Uchiyama and Kei Kurita. Their collaborative efforts have led to meaningful advancements in health diagnostics, showcasing the power of teamwork in innovation.

Conclusion

Riichi Maki's inventions highlight the importance of innovation in addressing critical health issues. His patented technologies not only offer promising tools for assessing metabolic and oral health but also illustrate the impact of dedicated inventors in transforming healthcare diagnostics.